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Based on the crystal structure of the VP7 major core protein of bluetongue virus serotype 10 (BTV-10) and that of the
top domain of the VP7 protein of African horsesickness virus serotype 4 (AHSV-4), chimeras and site-directed mutants of
the proteins were constructed and the products analyzed with respect to their properties and functions. Chimeras with the
central upper domain of BTV-10 VP7 replaced by that of AHSV-4 VP7 (construct BAB) formed trimers, as did the converse
construct (ABA). Further, both proteins exhibited the expected conformational epitopes of the constituent sequences. Using
BAB VP7 it was demonstrated that residues of the upper domain of AHSV-4 VP7 contribute to the observed insolubility of
the protein. By contrast, ABA VP7 protein was as soluble as wild-type BTV-10 VP7. Replacement of selected amino acid
residues in the top domain (e.g., A167 by R; F209 by T) improved the solubility of BAB VP7. Since the trimeric BAB and
ABA VP7 proteins did not form core-like particles (CLPs) when coexpressed with BTV VP3, it was concluded that trimerization
of chimeric VP7 is not sufficient for CLP formation. When the N-terminal region of the ABA protein (aa 1–120) was replaced
by the respective sequences of BTV VP7 (construct BBA), the protein aggregated and did not form CLPs with coexpressed
BTV VP3, most likely due to disruption of the required contacts between the N- and C-terminal regions of the bottom domain,
leading to incorrect folding of the chimera. q 1997 Academic Press
INTRODUCTION trimers and forming a T 13 l lattice (Grimes et al., 1995)
that overlays a subcore whose principal component is
Orbiviruses (family Reoviridae) have virions consisting
the VP3 protein (120 monomers, 60 dimers; D. Stuart,
of nonenveloped particles (86 nm in diameter) that en-
unpublished data). VP7 also interacts with the two outer
capsulate the 10-segment, double-stranded, RNA ge-
capsid proteins, VP2 and VP5 (Hewat et al., 1992b). In
nome. Among the recognized orbiviruses, bluetongue vi-
addition, there are VP7 trimer–trimer interactions in the
rus (BTV), the prototype orbivirus, the related African
core, most likely involving the VP7 carboxy termini which
horsesickness virus (AHSV), and epizootic hemorrhagic
extend out of the side of the trimer arrangement. At the
disease virus (EHDV), are transmitted by species of gnats
amino acid (aa) sequence level, BTV-10 VP7 protein is
and infect certain wild and domestic (livestock) verte-
highly conserved among BTV serotypes (95% se-
brates with occasional high morbidity and mortality (Mur-
quence identity, depending on the serotype) and closely
phy et al., 1971). Virions of these viruses have four major
related to the VP7 proteins of AHSV and EHDV (Iwata et
structural proteins (VP2, VP3, VP5, and VP7; Roy, al., 1992a,b).
1996a,b). Recent advances in understanding the macro- Although the BTV VP7 molecules contain a high per-
molecular organization of BTV have come from studies centage of hydrophobic residues, BTV-10 VP7 synthe-
involving cryoelectron microscopy (cryo-EM) of baculovi- sized by recombinant baculoviruses is soluble and, un-
rus-expressed BTV core-like particles (CLPs), and virus- der the appropriate conditions, forms crystals of VP7 tri-
like particles (VLPs), as well as from virus-derived cores mers (Basak et al., 1992). This property has allowed the
(Hewat et al., 1992a,b; Prasad et al., 1992). The BTV-10 3-dimensional structure of VP7 to be determined to a
VP7 protein (38 kDa) is a major constituent of the virus resolution of 2.6 A˚ (Grimes et al., 1995). Similarly, the
core with, per particle, 780 molecules arranged as 260 upper domain of the AHSV-4 VP7 has been determined
(Basak et al., 1996). From these data it has been shown
that the VP7 monomer is composed of two distinct do-1 Present address: Givaudan Roure Forschung AG, Ueberlandstrasse
138, CH-8600 Duebendorf, Switzerland. mains (Fig. 1A). The upper domain is formed by the cen-
2 Present address: Institute of Virology, Veterinary Faculty, University tral one-third of the polypeptide chain (aa 121–249),
of Zurich, Winterthurerstrasse 266a, CH-8057 Zurich, Switzerland. folded into an antiparallel b-sandwich. The lower domain3 To whom correspondence and reprint requests should be ad-
contains the N-terminal region composed of 5 a-helicesdressed at NERC Institute of Virology and Environmental Microbiology,
(aa 1–120) and four C-terminal a-helices (aa 250–349)Mansfield Road, Oxford, OX1 3SR, UK. Fax: //44 1865 559962. E-mail:
por@mail.nerc-oxford.ac.uk. that together form a bundle of nine helices with loops
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TABLE 1in-between (Fig. 1A). The two domains are twisted anti-
clockwise in the trimer so that the top domain of one Oligonucleotide Primers Used in PCR Reactions
monomer rests on the lower domain of the threefold re-
Name Nucleotide sequencelated subunit, primarily the C-terminal region.
In contrast to BTV, the AHSV VP7 forms flat hexagonal
Bac 1 5*-TGATAACCATCTCGCAA-3*crystals in the cytoplasm of infected cells (Burroughs et
Bac 2 5*-CGCACAGAATCTAGCGC-3*
al., 1994) and, likewise, large disc-shaped crystals when BT1 5*-GGCCGGATGCTGGCCCCCATGTGC-3*
expressed by a recombinant baculovirus (Chuma et al., BT4 5*-GGCCGGATGGTTGTGTTCTATATACTA-3*
AH2 5*-GGCCGGATGCAAATGCAAACATTCGGACCAA-3*1992). Due to this intrinsic insolubility, purification of a
AH3 5*-GGCCGGATGCCAAAGACGTATACCATAA-3*soluble form of the complete AHSV-4 VP7 has proved
RVD 5*-ACTGGAAATGTCTATCA-3*difficult and only the top domain has been crystallized
AH-Sma 5*-CGCGCCCCGGGTCCGAATGTTTGCATTTG-3*
(Basak et al., 1996). The X-ray structure of this top domain AH-Spe 5*-CGCGCACTAGTTTGGATAGATCGCTAGAC-3*
is very similar to that of the upper domain of BTV VP7 BT-Sma 5*-CGC5*GCCCCGGGCGTCAGCCTTATGGTTT-3*
BT-Spe 5*-CCGCGACTAGTATAGAACACAACCTGTATTTG-3*trimers, as expected from the high degree of sequence
APvuF 5*-GGGGCGATCGCTAGACACGGTT-3*similarity of the BTV and AHSV VP7 proteins (overall:
BPvuR 5*-GGGGCGATCGATCCATAGATATATAAAG-3*67% similarity, 46% identity). Despite this, it has not been
possible to substitute AHSV VP7 for BTV VP7 in the for- Note. FokI, SpeI, SmaI, and PvuI cloning sites are underlined. In
mation of chimeric CLPs using baculovirus-expressed oligonucleotide primers BT1, BT4, AH2, AH3, AH-Sma, AH-Spe, BT-
Sma, BT-Spe, APvuF, and BPvuR the sequences corresponding or com-BTV VP3 and AHSV VP7 proteins (unpublished data). By
plementary to the BTV-10 and AHSV-4 VP7 genes are shown in italics.contrast, when EHDV-1 VP7 was coexpressed with BTV
VP3, chimeric CLPs were formed (unpublished data; Le
Blois et al., 1991). EHDV-1 VP7 exhibits a 81% similarity
domain N-terminal a-helical region), aa residues 121and 64% identity with BTV-10 VP7 (Iwata et al., 1992a).
to 249 of AHSV VP7 (the b-sheet region of the top do-Using the available molecular and structural informa-
main) and aa 250 to 349 of BTV VP7 (the C-terminal a-tion for BTV and AHSV VP7 proteins, we have exchanged
helical region of the bottom domain). To amplify eachspecific regions and domains of the VP7 proteins of BTV
bottom domain region of BTV-10 VP7, the plasmid trans-and AHSV and determined the effects on protein solubil-
fer vector pAc10BTV7 DNA (Oldfield et al., 1990) wasity, folding, trimerization, and the ability to form CLPs with
used as template. This plasmid contains the BTV-10BTV VP3 protein. Further, the effects of replacing specific
VP7 gene inserted into a unique BamHI site in the par-aa of the AHSV VP7 (and BAB) protein by their counter-
ent transfer vector pAcYM1 (Matsuura et al., 1987). Twoparts from BTV VP7 were investigated. The mutant pro-
pairs of primers were used (Table 1), a forward primer,teins were expressed from the derived recombinant
Bac 1, together with the reverse primer BT1, and thebaculoviruses. Some improvement in solubility was iden-
forward primer BT4 together with the reverse primertified in the mutant BAB protein, but none for the mutant
Bac 2. The forward primer Bac 1 corresponded to anAHSV protein.
AcNPV sequence upstream of the BTV-10 VP7 gene in
the plasmid. The back primer, Bac 2, corresponded toMATERIALS AND METHODS
a region of the AcNPV genome some 60 nucleotides
Viruses and cells downstream of the VP7 insertion site in the plasmid
and represents a sequence of the complementary, non-
S. frugiperda (Sf) cells were grown in suspension coding DNA strand. The primers BT1 and BT4 each
and monolayer cultures at 287 in TC100 medium sup-
contain a FokI recognition site (underlined in Table 1)
plemented with 10% (v/v) fetal calf serum. Derivatives
and sequences that, for BT1, corresponded to the com-
of Autographa californica nuclear polyhedrosis virus
plementary strand residues 381 – 367 of the VP7 gene
(AcNPV) containing the wild-type BTV-10 VP7 gene
and, for BT4, the coding strand residues 756 – 774. Vent
(Ac10BTV7; Oldfield et al., 1990), or that of AHSV-4
DNA polymerase (New England Biolabs) was used for
(Ac4AHSV7; Chuma et al., 1992), and the various VP7
the PCR amplifications. The amplified products were
mutants that were constructed, were plaque purified and
treated with proteinase K, extracted with phenol, di-
propagated as described elsewhere (Brown and Faulk-
gested with BamHI and FokI, and purified using a QI-ner, 1977; King and Possee, 1992).
AEX II Gel Extraction kit as described by the manufac-
turer (Qiagen). The purified products were employedConstruction of recombinant transfer vectors and
for the subsequent cloning procedures. The sequencesbaculovirus expression vectors to synthesize chimeric
encoding the top domain of AHSV-4 VP7 were amplifiedBAB, ABA, BBA VP7, and ABB proteins
using, as template, the plasmid transfer vector pA-
c4AHSV7 (Chuma et al., 1992) and the forward primerFor the BAB construct, PCR was employed to con-
AH2 (corresponding to residues 360 – 381 of the AHSVstruct a chimeric VP7 gene encoding (in order) BTV-
10 VP7 aa residues 1 to 120 (representing the bottom VP7 coding sequence), and the reverse primer AH3
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(corresponding to the complement of residues 777 – tained sequences complementary to BTV-10 VP7 coding
residues 797–786. The sequence encoding AHSV-4 VP7759 of the AHSV-4 VP7 gene). As in the case of the
BTV gene, pAc4AHSV7 consisted of a copy of the AHSV- aa 250–350 was amplified by PCR using, as template,
pAc4AHSV7 (Chuma et al., 1992) and the forward primer4 VP7 gene inserted into the transfer vector pAcYM1.
Following PCR amplification and purification of the APvuF (containing a unique PvuI site), and reverse primer
Bac 2. The APvuF primer contained sequences corre-product, the AHSV VP7 gene fragment was digested
with FokI, then ligated into pAcYM1 (previously purified sponding to AHSV VP7 coding residues 761–779. The
two PCR products were digested with PvuI and BamHI,following digestion with BamHI) together with the ap-
propriately digested BTV-10 VP7 lower domain gene the products purified and cloned into pAcYM1 (previously
digested with BamHI and purified prior to ligation). Afragments, to form the recombinant transfer vector.
Clones of the resulting construct, pAcBAB7, were con- recombinant plasmid, pAcBBA7, with the correct VP7 ar-
rangement (see Fig. 1D) was recovered and character-firmed by sequence analyses (Sanger et al., 1977) to
have the expected chimeric VP7 arrangement (BAB) as ized by sequence analyses (Sanger et al., 1977). The ABB
(see Fig. 1E) construct, which consists of the N-terminalshown in schematic form in Fig. 1B.
The chimeric ABA and BBA VP7 genes were con- a-helix region of AHSV-VP7 and the remaining se-
quences of BTV VP7 was similarly generated using thestructed similarly. For ABA, two pairs of primers were
employed to amplify (by PCR) the N- and C-terminal re- forward primer RVD together with the reverse primer AH-
Sma (see Fig. 1E), as well as the forward primer BT-Smagions of AHSV VP7. These were the forward primer RVD
together with the reverse primer AH-Sma, as well as the and the reverse primer Bac2 (Table 1). The recombinant
plasmid, pAcABB7, was characterized as describedforward primer AH-Spe and the reverse primer Bac 2
(Table 1). The RVD primer corresponded to the AcNPV above.
sequence in the transfer vector that is upstream of the
Transfection and selection of recombinantunique EcoRV site, while the reverse AH-Sma primer
baculovirusesrepresented the sequence complementary to the VP7
coding residues 377–360. To facilitate subsequent ma-
The lipofection technique (Felgner et al., 1987) was
nipulations, the AH-Sma primer contained a downstream
used to cotransfect monolayers of Sf cells with recombi-
SmaI restriction enzyme site (Table 1). The AH-Spe for-
nant transfer vectors using Bsu36I triple-cut AcNPV DNA
ward primer corresponded to AHSV VP7 coding residues
(Kitts and Possee, 1993). Recombinant baculoviruses
774–791 and contained an SpeI restriction site to facili-
were initially selected on the basis of their lacZ-negative
tate subsequent manipulations (Table 1). As before, fol-
phenotypes, plaque purified, and propagated to high ti-
lowing PCR amplification the products were purified and
ters as described elsewhere (King and Possee, 1992).
digested with the appropriate enzymes (EcoRV, SmaI,
The transfer vectors pAcBAB7, pAcABA7, pAcBBA7, and
SpeI) for subsequent construction of the chimeric gene.
pAcABB7 were used to generate the recombinant bacu-
Similarly, the top domain sequences of the BTV VP7 gene
loviruses AcBAB7, AcABA7, AcBBA7, and AcABB7.
were amplified using the forward BT-Sma primer, which
corresponded to the coding residues 384–400, and the Site-directed mutagenesis, construction of transfer
reverse BT-Spe primer that was complementary to resi- vectors and isolation of recombinant baculoviruses
dues 767–747 of the BTV VP7 gene. Each primer pro- expressing other mutant VP7 proteins
vided a restriction enzyme site for cloning purposes
(SmaI and SpeI, respectively). Following PCR amplifica- Using the single-strand capacity of the baculovirus
transfer vector pAcCL29 (Livingstone and Jones, 1989),tion and purification, the fragments were digested with
the appropriate restriction endonucleases. To form the synthetic oligonucleotides were employed to prepare
specific VP7 mutants by the method described by Kunkelchimera, and since the recombinant transfer vector pA-
c4AHSV7 has internal BamHI and SpeI sites (Chuma et and associates (1987). For templates, the wild-type
AHSV-4 VP7 gene and the recombinant BAB VP7 geneal., 1992), it was initially digested with EcoRV and SpeI
and the linearized product recovered and ligated to the were recovered from the respective transfer vectors, pA-
c4AHSV7 and pAcBAB7, by excision with BamHI andamplified PCR fragments (previously digested with
EcoRV, SmaI, and SpeI prior to purification and ligation). subcloned into the BamHI site of pAcCL29. Two oligonu-
cleotides were employed for mutagenesis of theseThe resulting recombinant transfer vectors were charac-
terized and one, pAcABA7, was selected and confirmed genes: A167R (5*-GACCTGTCCTCTAGCGCCTGC-3*),
which was used to replace the AHSV VP7 alanine atby sequence analyses to have the appropriate arrange-
ment (see Fig. 1C). residue 167 (A167) by arginine (A167R), and F209T (5*-
AACGGTGACAGTAGTCCCTGG-3*), which was used toFor BBA VP7, the sequences encoding aa 1–249 of
BTV-10 VP7 (the first five helices of the bottom domain replace the AHSV VP7 phenylalanine at residue 209
(F209) by threonine (F209T). [The AHSV sequences referplus the whole of the top domain) were amplified using
Bac 1 and the reverse primer BPvuR (Table 1) which to the corrected sequence as deduced from the crystallo-
graphic data of the AHSV VP7 upper domain reported bycontained a flanking PvuI site. The BPvuR primer con-
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Basak and colleagues (1996), rather than the previously tein preparation and approximately 20 mg/well for par-
tially purified protein preparation) in carbonate coatingpublished VP7 sequence (see Iwata et al., 1992a).] In
these sequences the mutated anticodons are underlined. buffer (15 mM Na2CO3 , 36 mM NaHCO3 , pH 9.6) and
subsequently blocked with PBS containing 2% (w/v)Both oligonucleotides represented the complement of
the coding strand of the AHSV gene. The recombinant skimmed milk. For ELISA using wild-type recombinant
BTV and AHSV VP7 as well as chimeric ABA antigentransfer vectors were recovered and the mutated se-
quences confirmed by sequence analyses. Using these proteins were purified in homogeneity as described
above. For insoluble antigen such as BAB, a semipurifiedrecombinant transfer vectors, the recombinant baculo-
viruses AcAHSV7-A167R, AcAHSV7-F209T, AcBAB7- concentrated protein obtained after partial solubilization
(as described above) or resuspension of the pellet frac-A167R, and AcBAB7-F209T were isolated as described
above. tion were used. Mouse monoclonal antibodies (MAbs)
were raised to purified BTV-10 VP7 and characterized by
Solubility assays and purification of recombinant VP7 standard procedures (Kimura-Kuroda and Yasui, 1983).
protein by ammonium sulfate precipitation Mouse MAbs raised to purified AHSV-4 VP7 were kindly
provided by Drs. I. Casal and J. Martinez-TorrecuadradaInfected Sf cells were harvested 72 hr postinfection,
(Ingenasa, Spain). Standard procedures of incubation ofwashed in PBS, resuspended in cold TNN buffer (200
the primary antibody in serial two- or fivefold dilutionsmM Tris–HCl, pH 8.0, 150 mM NaCl, 0.5% Nonidet P-40),
were followed by addition of the alkaline phosphatase-and homogenized at 47. Cell debris and nuclei were then
conjugated secondary antibody (anti-mouse IgG, ob-pelleted by centrifugation (5 min at 2,500 g). As required,
tained from Sigma, and diluted 1:500 in PBS). The reac-ice-cold, saturated ammonium sulfate in 100 mM Tris –
tion was developed by addition of the enzyme substrateHCl, pH 7.5, was added to the cytoplasmic cell extracts to
(1 mg/ml of disodium r-nitrophenyl phosphate, pNPP,provide a final concentration of 20% v/v. The precipitated
(Sigma) prepared in 100 mM glycine, 1 mM MgCl2 , andprotein was pelleted by centrifugation and resuspended
1 mM ZnCl2 , pH 10.4). The reaction was stopped byin 10 mM Tris–HCl, pH 7.5, and dialyzed against the
addition of 3 N NaOH and the optical densities read atsame buffer at 47 overnight. Insoluble material was re-
405 nm using samples lacking the primary antibody asmoved by pelleting at 18,000 g for 10 min, and the soluble
controls.VP7 was stored at 0207 until required.
CLP analysesSDS–polyacrylamide gel electrophoresis (SDS–PAGE)
and Western blot analysis Cell extracts from coinfections involving recombinant
baculoviruses that expressed BTV VP3 and those thatSf cell monolayers were infected with a recombinant
expressed BTV VP7, or the mutant VP7 proteins, werebaculovirus using a m.o.i. of 5–10 PFU per cell (French
analyzed for the presence of CLPs by gradient centrifuga-and Roy, 1990). Cells were harvested at 72 hr postinfec-
tion as described by French and Roy (1990). CLPs weretion, washed with PBS, and lysed at 47 in TNN. Samples
examined by electron microscopy after resuspension inwere then suspended in protein dissociation buffer (10%
10 mM Tris–HCl, pH 7.5, and absorption on to a carbon-(v/v) b-mercaptoethanol, 10% (w/v) SDS, 25% (v/v) glyc-
coated copper 400 mesh EM grid for 2–3 min, followederol, 10 mM Tris–HCl, pH 6.8, and 0.02% (w/v) bromophe-
by a dH2O wash and negative staining with 2% (w/v)nol blue) and either heated at 377, or boiled at 1007, for
uranyl acetate. Grids were examined at 100 kV in a JEOL10 min and the products subsequently resolved by 10%
100CX electron microscope under low dose conditions.SDS–PAGE, followed by staining with Coomassie bril-
liant blue. For Western blot analysis, proteins from gels
were transferred onto a PVDF membrane by standard RESULTS
blotting procedures. Membranes containing protein were
Domain replacement between BTV-10 and AHSV-4incubated with the specified antiserum diluted 1:1000 in
VP7 proteins and construction of chimeric BAB VP7blocking buffer (5% (w/v) skimmed milk, 0.05% (v/v)
Tween-20 in PBS), followed by incubation with the sec- Sequence analyses of the genes encoding the four
ondary antibody conjugated with alkaline phosphatase, major structural proteins (VP2, VP3, VP5, VP7) of BTV-10,
and the bound products were identified using the alka- EHDV-1, and AHSV-4 have revealed that the BTV and
line phosphatase substrate NBT-BCIP (GIBCO-BRL) in EHDV genes are more closely related than either is to
0.1 M Tris–HCl, pH 8.5, 0.1 M NaCl, and 0.05 M MgCl2 . those of AHSV (Roy et al., 1991; Iwata et al., 1992a,b).
Nevertheless crystallographic analyses have shown that
Enzyme-linked immunosorbent assay (ELISA)
the top domains of BTV and AHSV VP7 proteins are tri-
meric and structurally similar (Grimes et al., 1995; BasakConventional ELISA procedures were performed as
described elsewhere (Gould et al., 1985). In brief, Micro- et al., 1996). In the AHSV and BTV VP7 top domains, the
two proteins exhibit some 29% aa identity and 51% aaELISA plates (Nunc) were coated overnight with an opti-
mal concentration of antigen (10 mg/well for purified pro- homology when one considers aa of similar character.
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Only the structure of the top domain of AHSV-4 VP7 is the lower domain of AHSV VP7 while the MAbs 8BH8,
8DF4, and 8BD4 map to the top domain of AHSV VP7.known (Basak et al., 1996). For the bottom domains, se-
When the BAB VP7 protein was coexpressed with BTV-quence comparisons between the BTV and AHSV VP7
17 VP3 protein no CLPs were detected (data not shown),proteins (Iwata et al., 1992a,b) indicate that the proteins
although both proteins were synthesised at high levels,are more similar (some 65% identity and 82% similarity
and in control studies the coexpressed BTV VP3 andin the N terminal region; 42% identity and 61% homology
VP7 proteins gave CLPs (French and Roy, 1990, data notin the C-terminal region).
shown), indicating, in the case of the chimeric VP7, thatTo examine the structural and functional relationships
BAB VP7 and BTV VP3 proteins were structurally incom-of the BTV and AHSV VP7 proteins, a chimeric protein
patible, possibly due to the protein insolubility, or thewas constructed containing the bottom domain of BTV
particular conformation of the BAB VP7 protein and itsand the top domain of AHSV VP7. The chimera, desig-
trimers.nated BAB VP7, is shown in schematic form in Fig. 1B,
including the junction BTV and AHSV sequences. The Synthesis and analysis of the ABA VP7 chimeric
recombinant protein was expressed in insect cells from protein
a recombinant baculovirus, AcBAB7, giving levels of ex-
From analyses of the available crystallographic andpression and an electrophoretic mobility in SDS–PAGE
amino acid sequence data it has been suggested thatcomparable to those of the wild-type BTV-10 (Fig. 2, lanes
the distribution of the residues of the top domain may1 and 3). Chimeric BAB VP7, recovered from the pellets
be critical in relation to the observed solubility of the BTVfollowing the lysis of AcBAB7-infected cells, was assayed
VP7 and lack of observed solubility in the case of AHSVfor trimer formation as described previously (Clapp and
VP7 protein (Basak et al., 1996). To provide informationPatton, 1991). To assay for trimerization, purified wild-
on the potential bottom domain of the AHSV VP7 proteintype BTV-10 VP7 or chimeric BAB VP7 protein prepara-
and to study the impact of the top domain residues intions were resuspended in the SDS–PAGE sample
protein solubility and suitability of the construct for CLPbuffer, incubated at 377 for 10 min, and the trimers were
formation with expressed BTV VP3, initially a chimericdetected following resolution in 10% SDS–PAGE. To de-
ABA VP7 gene was prepared that combined the top do-nature trimers, the samples were boiled at 1007 for 10
main of BTV with the bottom domain of AHSV VP7 (see
min prior to electrophoresis. Similar to BTV-10 VP7, when
Fig. 1C). The gene was expressed in insect cells using
samples of BAB VP7 were incubated only at 377 prior to
the recombinant baculovirus AcABA7. In this protein, aa
SDS–PAGE, it was observed that the BAB VP7 protein
residues corresponding to both regions of the a-helical
preparations contained trimers in addition to monomers
bottom domain originated from AHSV-4 VP7, and resi-
(Fig. 2, lane 2 for BTV-10 VP7, lane 4 for BAB VP7). Upon dues constituting the top b-sheet domain came from
denaturation by boiling at 1007 for 10 min, only monomers BTV-10 VP7. Interestingly, by SDS–PAGE the ABA VP7
were detected (Fig. 2, lane 1 for BTV-10 VP7, lane 3 for protein exhibited a slightly faster electrophoretic mobility
BAB VP7). The use of the pellet fractions rather than (Fig. 4A, lane 5) than either the BTV (Fig. 4A, lane 1) or
purified BAB VP7 protein was due to the fact that upon AHSV VP7 proteins (Fig. 4A, lane 3). ABA trimers were
extraction with nonionic detergents (Materials and Meth- also detected in the expressed ABA protein preparations
ods), and in the absence of urea, the majority of the BAB (Fig. 4A, lane 6). In ELISA the protein gave strong reac-
VP7 protein was found to be insoluble and remained in tions with the available six conformation-dependent
the pellet after low speed centrifugation (data not shown), MAbs raised against purified BTV VP7. Based on these
similar to the expressed wild-type AHSV-4 VP7. This was data together with the analysis of BTV-10 VP7 mutants
in contrast to BTV VP7 where significant amounts of VP7 (E. Nason, personal communication) it was concluded
monomers were recovered in the supernatant fraction as that these 6 MAbs map to the upper domain of BTV-
well as in the pellet (data not shown). 10 VP7 (see Fig. 3A; compare the data with the results
As shown in Fig. 3A, the expressed BAB protein did obtained with the BAB protein described above).
not react in ELISA to any significant extent with six con- In ELISA, the ABA protein also reacted specifically with
formation-dependent, anti-BTV VP7 MAbs, all of which the anti-AHSV-4 VP7 MAbs 10AB1 and 10BH9 and also
map to the top domain (compare the results with the with MAb 10AB1 in Western blot analysis (Fig. 4B, lane
results obtained with the ABA construct, Fig. 3A). In 3). The ABA chimera did not provide responses in ELISA
ELISA, BAB VP7 reacted significantly with three of five with MAbs 8BH8, 8DF4, or 8BD4 at levels comparable
available anti-AHSV VP7 MAbs (8BH8, 8DF4, 8BD4). to the reactions obtained with AHSV-4 VP7, or the BAB
These MAbs are specific to AHSV VP7 and do not cross- chimera (Fig. 3B). Based on these data it was concluded
react with BTV VP7 (Fig. 3B). The expressed BAB protein that MAb 10AB1 recognized a linear epitope in the lower
did not react with MAbs 10AB1 or 10BH9 in ELISA at domain of AHSV VP7 and that MAb 10BH9 also recog-
levels comparable to the results obtained with AHSV-4 nized a lower domain epitope, whereas the other three
VP7 and the chimera ABA VP7 (Fig. 3B, see later). The AHSV MAbs recognized epitopes in the upper domain
of the AHSV VP7 protein.data suggest that the MAbs 10AB1 and 10BH9 recognize
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cloning manipulations, an arginine was introduced at the
junction site and in lieu of the normal BTV-10 VP7 isoleu-
cine residue (residue 251) or corresponding AHSV-4 VP7
threonine (Iwata et al., 1992a). The BBA VP7 protein was
expressed and analyzed for solubility, trimerization, and
ability to form CLPs when coexpressed with BTV VP3.
Like the BTV or AHSV VP7 proteins, the BBA protein was
expressed to high levels and exhibited an identical elec-
trophoretic mobility in SDS–PAGE, but no CLPs were
formed on coexpression with BTV VP3 (data not shown).
In contrast with the BTV or ABA proteins, but like the
AHSV and BAB proteins, essentially all the BBA VP7 was
recovered in the pellet after detergent extraction and sepa-
ration of infected cell lysates by low-speed centrifugation
(Fig. 5A, lane 3). However, no trimers were detected in
FIG. 2. Expression and trimerisation assays of BTV-10 VP7 and BAB samples that were not boiled prior to SDS–PAGE (data
VP7 proteins. The expression of authentic and chimeric proteins recov-
not shown). Surprisingly, the expressed protein did notered from Sf cells infected with the recombinant baculovirus Ac10BTV7
react with the available, top domain, conformation-depen-that synthesized wild-type BTV VP7 (lanes 1 and 2) and the recombinant
AcBAB7 that produced BAB VP7 (lanes 3 and 4). Lane 1, BTV VP7 dent anti-BTV-10 VP7 MAbs in ELISA (data not shown),
following heat denaturation for 10 min at 1007; lane 2, BTV VP7 incu- indicating that the conformational epitopes of the upper
bated at 377 prior to SDS–PAGE. In lane 3 is shown the heat denatured domain were disrupted and that the chimeric protein had
(10 min at 1007) chimeric BAB VP7 and in lane 4 BAB VP7, incubated
not folded correctly. These results indicate that the aminoat 377 prior to SDS–PAGE. The positions of the VP7 monomers and
acid and structural differences between N-terminal heli-trimers are indicated by arrows. Molecular weight markers are shown.
ces 1–5 of BTV-10 VP7 and the C-terminal helices 6–9 of
AHSV-4 VP7 not only precluded interactions with BTV VP3,
When coexpressed with BTV VP3, the ABA protein but also drastically affected the conformation of the upper
failed to produce CLPs as determined by standard domain of the protein. To investigate this further, a second
assays (French and Roy, 1990, data not shown), indicat- chimeric ABB VP7 was constructed in which the first N-
ing that the two proteins were structurally incompatible, terminal helices represented AHSV VP7, while the re-
possibly due to the particular conformation of the ABA maining molecule represented BTV VP7. The chimeric
VP7 protein and its trimers. DNA (see Fig. 1E) was similarly expressed by a recombi-
nant baculovirus and the solubility of the recombinant pro-
Synthesis of BBA and ABB VP7 chimeric molecules
tein was examined. The protein behaved similarly to that
and analysis of interdomain interactions
of BBA protein (see Fig. 5B). Although ABB does not pos-
sess any mutated residue as in the case of BBA, neverthe-The bottom domain of VP7 consists of nine helices
less, correct folding was also disrupted and the proteinand is split in two sections, with four C-terminal helices
was as insoluble as BBA VP7. As expected, ABB alsopositioned generally over the five N-terminal helices (see
failed to form CLPs (data not shown).Fig. 1A). To determine whether the BTV N-terminal helices
were all that was required for interaction with VP3 in the
Replacement of AHSV VP7 Ala 167 by Arg (A167R)formation of CLPs and the impact of the helices from
or Phe 209 by Thr (F209T) and the effect on thedifferent proteins on the trimerization of VP7, a BBA chime-
trimerization and solubility of AHSVric VP7 gene was constructed. In this construct, the first
and chimeric BAB VP7 proteinsfive N-terminal helices of the ABA chimera were substi-
tuted by those of BTV (see Fig. 1D for a schematic of the In the AHSV-4 VP7 sequence, aa residue 167 is an
alanine (A167) while in the comparable sequence of BTV-construct). As indicated in the schematic, and due to the
FIG. 1. Construction of chimeric BAB, ABA, BBA, and ABB VP7 proteins. (A) A schematic of the arrangement of BTV-10 VP7 is shown (Grimes et
al., 1995) in which the two domains of the protein are illustrated: the top b-sheet domain (aa 121–249) and the bottom a-helical domain that is
composed of two regions, the N-terminal region, aa 1–120, and the C-terminal region, aa 250–349. The helices of the bottom domain are numbered.
In (B) is shown a schematic of the chimeric BAB VP7 protein which consists of the top domain of AHSV-4 VP7 and the bottom domain of BTV-10
VP7. The aa sequences at the junction sites are shown with the BTV sequences above and the AHSV sequences (in italics) shown below the
junctions. In (C) is shown a schematic of the chimeric ABA VP7 protein consisting of the top domain of BTV-10 VP7 and the bottom domain of
AHSV-4 VP7. The aa sequences at the junctions are provided. In (D) is shown a schematic of the arrangement of a chimeric BBA VP7 consisting
of the N-terminal bottom domain region and top domain region of BTV followed by the C-terminal region of the bottom domain of AHSV. The aa
sequences at the junction are shown. In this case the BTV VP7 isoleucine at aa 251 (threonine in the comparable AHSV sequence; Iwata et al.,
1992a; Basak et al., 1996) was exchanged for an arginine due to the cloning manipulations. In (E) is shown a schematic of the arrangement of a
chimeric ABB VP7 consisting of the N-terminal bottom domain region of AHSV, followed by the top domain and C-terminal bottom domain region
of BTV. The aa sequences at the junction are shown.
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out as described under Materials and Methods, and the
recombinant baculoviruses prepared and used to synthe-
size the respective proteins, AHSV7-A167R VP7, AHSV7-
F209T VP7, BAB7-A167R VP7, and BAB7-F209T VP7.
Both mutations had a stronger effect on the solubility
of the chimeric BAB VP7 protein than on AHSV VP7. In
fact, neither mutation improved the solubility of AHSV
VP7 as evidenced by the observation that the AHSV7-
A167R and AHSV7-F209T VP7 proteins were recovered
in the pellet fractions following lysis of infected cells in
the presence of a nonionic detergent and low speed
centrifugation (Figs. 6A and 6B, lane 3). By comparison,
some of the mutant BAB7-A167R and BAB7-F209T pro-
teins were recovered in the supernatant (as well as pellet
fractions) following cell lysis and low speed centrifuga-
tion (Figs. 6C and 6D, lanes 2 and 3). However, based
on the relative amounts recovered in the respective pellet
and supernatant fractions, the mutant BAB VP7 proteins
did not appear to be as soluble as BTV-10 VP7, and little
was recovered following ammonium sulfate precipitation.
Further in coexpression studies with BTV VP3, none of
the mutant proteins formed CLPs with coexpressed BTV
VP3 (data not shown).
DISCUSSION
The self-assembly of the BTV VP3 and VP7 proteins
into CLPs by coexpression of their genes in insect cells
by recombinant baculoviruses (French and Roy, 1990)
provides a useful in vitro model for studying protein–
protein interactions in virus assembly. The crystal struc-
ture of BTV-10 VP7 (Grimes et al., 1995) exhibits a b-
sandwich structure for the top domain, resembling the
jelly roll motif of the influenza virus hemagglutinin and
many other viral capsid proteins. The a-helical bottom
FIG. 3. ELISA analysis of VP7 proteins using anti-BTV-10 or anti- domain is not commonly observed among viral capsid
AHSV-4 VP7 MAbs. Micro-ELISA plates were coated with the purified proteins. The crystallographic data have implicated thewild-type BTV-10 VP7 (black boxes), or wild-type AHSV-4 VP7 (grey
lower domain, especially the flat hydrophobic area ofboxes), or recombinant ABA VP7 (boxes with vertical lines), or approxi-
helix 2 and adjoining loops at the base of the VP7 trimers,mately 20 mg of semipurified recombinant BAB VP7 (boxes with hori-
zontal lines). In (A) a panel of 6 MAbs (H1.1 to H1.6) raised against in solving the mismatch that occurs in the interactions
purified recombinant BTV-10 VP7 was tested with each antigen using of 260 VP7 trimers with a smaller number of underlying
1:1,000 to 1:24,000 dilutions of sera. The OD readings at 405 nm of a VP3 molecules (120 molecules, arranged as dimers) (Bur-1:10,000 dilution of each MAb are shown. In (B) a panel of 5 MAbs
roughs et al., 1995; D. Stuart, personal communication).(8BH8, 10AB1, 8DF4, 10BH9, and 8BD4) raised against purified recom-
A chimeric BAB VP7 protein, combining the top domainbinant AHSV-4 VP7 was tested with each antigen using 1:1,000 to
1:10,000 dilutions of sera. The OD readings at 405 nm of a 1:5,000 of AHSV-4 VP7 with the bottom domain of BTV-10 VP7,
dilution of each MAb are shown. was expressed and analyzed for its solubility, antigenic
properties, and CLP formation with BTV VP3. It was
shown to possess the domain-related antigenic determi-10 VP7 it is an arginine (see Iwata et al., 1992a, and
Basak et al., 1996). At aa position 209 in the AHSV-4 nants characteristic of the respective BTV and AHSV VP7
proteins, confirming the correct folding of both domains.VP7 there is a phenylalanine, while in the corresponding
sequence of BTV-10 VP7 there is a threonine (see Basak Similar to AHSV VP7, BAB VP7 formed trimers. However,
no CLPs were detected upon coexpression of BAB withet al., 1996). The substitution of A167 and F209 by the
aa residues located in equivalent positions in BTV-10 BTV VP3, possibly due to its insolubility and tendency to
form aggregates. The chimeric protein ABA VP7, pos-VP7 (R and T) has been suggested as a means to improve
the solubility of AHSV-4 VP7 (Basak et al., 1996). To inves- sessing the top domain of BTV and the bottom domain
of AHSV VP7 also formed trimers and was highly soluble.tigate this issue, and to obtain soluble protein for crystal-
lographic purposes, the indicated mutations were carried The fact that ABA VP7 did not form CLPs with BTV VP3
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FIG. 4. Expression and characterization of BTV, AHSV, and ABA VP7 proteins. In (A) VP7 proteins were assayed for trimerization, separated by
10% SDS–PAGE, and stained with Coomassie brilliant blue. Lane 1 shows BTV-10 VP7, lane 3 AHSV-4 VP7, and lane 5 the chimeric ABA VP7
protein. All three samples were heat denatured at 1007 prior to SDS–PAGE. Lane 2 shows BTV-10 VP7, lane 4 AHSV-4 VP7, and lane 6 the chimeric
ABA VP7 protein. The three samples were incubated at 377 prior to SDS–PAGE. In (B) proteins were electroblotted onto membranes and reacted
with anti-AHSV-4 VP7 MAb 10AB1 in Western blot analyses. In (B) lane 1 shows the boiled sample of BTV-10 VP7, lane 2 shows the boiled sample
of AHSV-4 VP7, lane 3, boiled ABA VP7.
indicates that the aa composition and/or folding of the domain in contributing to the insolubility of AHSV-4 VP7.
bottom domain significantly influence the interactions be- Further, that the a-helical and b-sheet domains of VP7
tween VP7 trimers and the underlying VP3 scaffold, and fold independently involving specific amino acid interac-
that trimerization of VP7 is not by itself a sufficient prereq- tions within the domains. The bottom domain of BTV VP7
uisite of CLP formation. These findings also support the is more hydrophobic than the respective area of AHSV-
crystallographic data which have implicated the upper 4 VP7 (Basak et al., 1996). The lower part of the bottom
domain is composed of the N-terminal helices 1 to 5.
Although the amino acid composition of these helices,
particularly helix 2, is similar between the two related
VP7 proteins, several specific residues likely to contrib-
ute to the interactions with the VP3 scaffold are different.
Thus alanine (A27) of BTV-10 VP7 is replaced by P in
AHSV-4 VP7, V24 by S, N28 by G, L45 by N, G47 by S,
T53 by Q, P79 by D. Without the crystal structure of the
bottom domain of AHSV-4 VP7 it is difficult to evaluate
the precise orientation of these variable residues, how-
ever, they might account for the inability of ABA VP7 to
form CLPs when coexpressed with BTV VP3.
To study the interactions between helices within the
bottom domain, the N-terminal a-helices 1 to 5 (aa 1–
120) of the ABA chimeric protein, originating from AHSV-
FIG. 5. Solubility assay of the expressed BBA and ABB VP7 proteins. 4 VP7, were replaced by the respective residues of BTV
Following lysis in the presence of a nonionic detergent, extracts of
VP7. The new VP7 chimera, BBA, was expected to pos-Sf cells infected with the AcBBA7 (A) and ACABB7 (B) recombinant
sess the bottom surface of BTV VP7. Since none of thebaculoviruses were separated by low-speed centrifugation (Materials
and Methods). The fractions from each step of purification were re- residues of the C-terminal part of the lower domain con-
solved by 10% SDS–PAGE and stained with Coomassie brilliant blue. tribute to the base of the trimer, the BBA chimera was
Lane 1 shows the infected cell lysate, lane 2 the supernatant after low- expected to interact with BTV VP3 to form CLPs. How-speed centrifugation, and lane 3, the pellet following the low-speed
ever, unlike the soluble and trimeric BTV and ABA VP7centrifugation of the original extract. The positions of VP7 and molecu-
lar weight markers are indicated. proteins, the BBA VP7 was recovered in aggregates fol-
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In other studies it has been reported that single amino
acid substitutions can significantly improve protein solu-
bility (Zhao and Sommerville, 1992; Izard et al., 1994;
Jenkins et al., 1996). Based on the available crystallo-
graphic data, A167 and F209 have been proposed as
candidates for mutations to increase the solubility of
AHSV-4 VP7. The arginine at aa position 168 of BTV-10
VP7 forms part of an RGD motif, implicated in cellular
attachment of bluetongue cores, similarly to the foot and
mouth disease virus where the RGD site is involved in
attachment to an integrin receptor (Fox et al., 1989; Logan
et al., 1993; Mason et al., 1994). The mutations were
carried out both in the wild-type AHSV VP7 and chimeric
BAB VP7 and were shown to have a more pronounced
effect in case of BAB VP7. Both mutated BAB7-A167R and
BAB7-F209T proteins were recovered in the supernatant
following lysis of infected cells with nonionic detergent.
Mapping the hydrophobicity plots to the solvent-accessi-
ble surface of BTV-10 VP7 trimers have shown the pres-
ence of a large hydrophilic area composed of strand bC
and h1 (aa 168–176, including the RGD motif) of the top
domain of one monomer, and the C-terminal helix 9 of
the adjoining monomer (Basak et al., 1996). R168, which
in AHSV is replaced by A167, forms part of this area. The
lower solubility of AHSV VP7 mutant A167R compared
with the same mutation in the chimeric BAB VP7 might
reflect the impact of the C-terminal helix 9, as the C-
terminus of AHSV VP7 is more hydrophobic with L346
replacing R345 of BTV VP7.
The related BTV-10 and AHSV-4 VP7 proteins have
FIG. 6. Solubility assays of AHSV VP7, BAB VP7 mutant proteins. Sf
only 45% identity. Nevertheless, replacement of entirecells were infected with recombinant baculoviruses expressing wild-
domains was successful between these proteins. Thetype or mutant VP7 proteins, lysed in the presence of a nonionic deter-
gent, and fractionated by low-speed centrifugation. Whole cell lysates, chimeric VP7 proteins folded correctly and retained the
supernatant, and pellet fractions were resolved by 10% SDS–PAGE epitopes of the respective domains. Analysis of the ef-
following boiling, then stained either with Coomassie brilliant blue (A fects of substitution of helices within the bottom domain
and B) or analyzed by Western immunoblotting using polyclonal VP7
have, however, revealed that such mutations interferedantibody (C and D). Whole cell lysates are shown in lane 1, superna-
with protein folding, indicating that the interdomaintants in lane 2, and pellet fractions in lane 3. (A) AHSV7-A167R; (B)
AHSV7-F209T VP7; (C) BAB7-A167R VP7; (D) BAB7-F209T VP7 protein. amino acids interactions are very specific. ABA VP7 crys-
The positions of VP7 and molecular weight markers are indicated. tallization trials are underway to determine the structure
of the bottom domain. These data should indicate which
amino acid residues of the AHSV-4 VP7 protein interactlowing the cell lysis. Further, ELISA tests revealed loss
with the AHSV VP3 scaffold and open up the opportunityof conformational epitopes, indicating that BBA VP7 was
for precise mapping of such residues by site-directednot folded correctly. At the junction site, BBA VP7 has an
mutagenesis.arginine replacing an isoleucine residue (I251), which
may have disrupted the protein structure similar to the
previously reported substitution of a conserved lysine ACKNOWLEDGMENTS
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